✦ LIBER ✦

Preclinical phase II studies in human tumor lines: A European multicenter study

✍ Scribed by Boven, Epie; Winograd, Benjamin; Fodstad, Ãystein; Lobbezoo, Marinus W.; Pinedo, H.M.

Book ID: 120033367
Publisher: Elsevier Science
Year: 1988
Weight: 742 KB
Volume: 24
Category: Article
ISSN: 0277-5379
DOI: 10.1016/S0277-5379(98)90039-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical phase II study of ifosfamide

Preclinical phase II study of ifosfamide in human tumour xenografts in vivo

✍ D. P. Berger; H. H. Fiebig; B. R. Winterhalter; E. Wallbrecher; H. Henss 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 417 KB

Phase II study of carminomycin in a huma

Phase II study of carminomycin in a human tumor cloning assay

✍ Marcel Rozencweig; Charlotte Sanders; William Rombaut; Nadine Crespeigne; Genevi 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 305 KB

The anticancer activity of carminomycin was investigated in a human tumor cloning assay. No efficacy could be identified in the WiDr and the MCF7 cell lines which were highly responsive to doxorubicin. In addition, drug testing experiments were carried out in samples of various malignancies freshly

Phase II study of ametantrone in a human

Phase II study of ametantrone in a human tumor cloning assay

✍ Rozencweig, Marcel; Sanders, Charlotte; Rombaut, William; Crespeigne, Nadine; Ke 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 447 KB

FOLFIRI as second-line chemotherapy for

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

✍ Zaniboni, Alberto; Aitini, Enrico; Barni, Sandro; Ferrari, Daris; Cascinu, Stefa 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 179 KB

A multicenter phase II study of cisplati

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

✍ Véronique Diéras; JeanPaul Guastalla; JeanMarc Ferrero; Hervé Curé; Béatrice Web 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

A multicenter Phase II study of bortezom

A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas

✍ Robert G. Maki; Andrew S. Kraft; Kelly Scheu; Jennifer Yamada; Scott Wadler; Cri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views